Мақаланы E-mail арқылы жіберу Pulsed Dendritic Cells for the Therapy of Experimental Glioma
- Авторлар: Chekhonin I.V.1, Gurina O.I.1, Cherepanov S.A.2, Abakumov M.A.2, Ionova K.P.1, Zhigarev D.K.1, Makarov A.V.1, Chekhonin V.P.1,2
-
Мекемелер:
- V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
- Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
- Шығарылым: Том 161, № 6 (2016)
- Беттер: 792-796
- Бөлім: Microbiology and Immunology
- URL: https://ogarev-online.ru/0007-4888/article/view/237786
- DOI: https://doi.org/10.1007/s10517-016-3512-1
- ID: 237786
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
We obtained the morphologically, cytofluorometrically, and functionally mature dendritic cells from rats that were pulsed with antigens of the C6 glioma tissue extract. The concentrations of angiogenesis antigens (VEGF, VEGFR-1, and VEGFR-2) and periglioma zone proteins (GFAP, connexin 43, and BSAT1) in the pulsing extract were measured by ELISA. Our results drove us to a conclusion that despite mature phenotype of pulsed dendritic cell, the antigenic composition of glioma tissue extracts should be modified.
Авторлар туралы
I. Chekhonin
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Хат алмасуға жауапты Автор.
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow
O. Gurina
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow
S. Cherepanov
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow
M. Abakumov
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow
K. Ionova
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow
D. Zhigarev
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow
A. Makarov
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow
V. Chekhonin
V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation; Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: ivan-chekhonin@yandex.ru
Ресей, Moscow; Moscow
Қосымша файлдар
